Purchase Order 75N95024P00578

Award Date 9/9/24
Potential Completion Date 9/8/25
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $87,672.00 Firm Fixed Price Purchase Order contract to Glixx Laboratories, Inc., a self-certified small disadvantaged business. The contract is part of the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, and has an ultimate completion date of November 30, 2015. The contract does not have a set-aside designation.</p>
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $63,800.00 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company, to perform &quot;Small Molecule Target Deconvolution via Cellular Thermal Shift Assay (CETSA).&quot; This requirement was originally posted as a Sources Sought notice, seeking information on qualified sources to perform CETSA experiments, including sample...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,600.00 firm fixed-price purchase order contract to Neurostatus-Uhb AG, a foreign-owned for-profit organization, for a NeuroStatus e-test license and EDSS training. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025. The contract was not set aside for any specific business designation.</p>
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $12,000.00 firm-fixed-price purchase order contract to Vivpro Corp, a self-certified small disadvantaged business, for subscription licenses. The contract has an ultimate completion date of June 24, 2025 and was awarded on June 13, 2024. This contract does not have a set-aside designation.</p>
This is a $156,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Oncolead GMBH &amp; CO. KG, a for-profit limited liability company located in Germany. The contract does not have a set-aside designation and was awarded on September 23, 2015 with a period of performance ending on September 30, 2016. As NIDA is the agency responsible for advancing research on drug use and addiction, this contract is likely supporting the...
This federal contract award was granted by the National Institute on Drug Abuse (NIDA), a civilian agency, to Idea Bio-Medical LTD, a for-profit organization, on September 9, 2015. The contract has a firm fixed price of $122,500.00 and a completion date of October 30, 2015. No set-aside designation was used. The contract type is a purchase order and does not appear to be associated with a larger contract vehicle. The provided information does not indicate any major subcontractors or additional...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,451,736.00 cost-plus-fixed-fee contract to Medispin Inc., a small business, for R&amp;D in physical science. The 3-year contract (ultimate completion date of Nov 30, 2009) was awarded on Sep 22, 2006 under a total small business set-aside. The contract is for research and experimental development activities related to the agency's mission.</p>
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, has awarded a $27,000 firm-fixed-price purchase order contract to the Massachusetts Institute of Technology (MIT) for MWORKS CONSULTING &amp; DEVELOPMENT services. The contract period of performance is from September 20, 2024 to March 19, 2025, with a final completion date of March 19, 2025. This contract does not have a set-aside designation.</p>

The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.

Generated 9/11/24, 9:27 AM